Evolution of antibiotic resistance in gram-positive pathogens

A. Marchese, G. C. Schito, E. A. Debbia

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Staphylococcus aureus is a common cause of soft-tissue infection, e.g. impetigo, cellulitis, or wound infection, and causes osteomyelitis, arthritis, bacteremia with metastatic infection, and scalded skin and toxic shock syndromes. Coagulase-negative staphylococci have become increasingly important causes of nosocomial bacteremia associated with invasive monitoring, intravascular catheters and prosthetic heart valves or joints. Most staphylococci produce b-lactamase and are resistant to penicillin. An increasing proportion of S. aureus have intrinsic resistance to methicillin (MRSA) and present major problems in hospitals for the control of cross infection. The glycopeptides, teicoplanin and vancomycin, are the antibiotics of first choice for treatment of these infections. After the first report describing a Japanese clinical isolate of vancomycin-resistant S. aureus (VRSA), several papers have documented the emergence of these microorganisms. Since the development and spreading of this phenomenon which is perceived as a fearsome threat to the already difficult therapy of nosocomial infections due to the prevalence of heterogeneous vancomycin resistance, we found the incidence of MRSA exceeds 35% in our hospital. Out of 179 methicillin-resistant S. aureus isolated during 1997-1998, two strains (1.1%) gave subclones with vancomycin MICs of 8 mg/L. PFGE showed identical restriction patterns for both isolates, suggesting transfer of a single clone between two different patients.

Original languageEnglish
Pages (from-to)459-462
Number of pages4
JournalJournal of Chemotherapy
Volume12
Issue number6
Publication statusPublished - 2000

Fingerprint

Vancomycin
Methicillin-Resistant Staphylococcus aureus
Microbial Drug Resistance
Staphylococcus aureus
Cross Infection
Bacteremia
Staphylococcus
Impetigo
Vancomycin Resistance
Teicoplanin
Soft Tissue Infections
Methicillin Resistance
Cellulitis
Glycopeptides
Coagulase
Heart Valves
Wound Infection
Osteomyelitis
Septic Shock
Infection

Keywords

  • Glycopeptides
  • Gram-positive bacteria
  • Methicillin-resistance
  • Staphylococcus aureus
  • Teicoplanin
  • Vancomycin

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)

Cite this

Marchese, A., Schito, G. C., & Debbia, E. A. (2000). Evolution of antibiotic resistance in gram-positive pathogens. Journal of Chemotherapy, 12(6), 459-462.

Evolution of antibiotic resistance in gram-positive pathogens. / Marchese, A.; Schito, G. C.; Debbia, E. A.

In: Journal of Chemotherapy, Vol. 12, No. 6, 2000, p. 459-462.

Research output: Contribution to journalArticle

Marchese, A, Schito, GC & Debbia, EA 2000, 'Evolution of antibiotic resistance in gram-positive pathogens', Journal of Chemotherapy, vol. 12, no. 6, pp. 459-462.
Marchese A, Schito GC, Debbia EA. Evolution of antibiotic resistance in gram-positive pathogens. Journal of Chemotherapy. 2000;12(6):459-462.
Marchese, A. ; Schito, G. C. ; Debbia, E. A. / Evolution of antibiotic resistance in gram-positive pathogens. In: Journal of Chemotherapy. 2000 ; Vol. 12, No. 6. pp. 459-462.
@article{f7d8609e05514a67bca335b4fd0f4886,
title = "Evolution of antibiotic resistance in gram-positive pathogens",
abstract = "Staphylococcus aureus is a common cause of soft-tissue infection, e.g. impetigo, cellulitis, or wound infection, and causes osteomyelitis, arthritis, bacteremia with metastatic infection, and scalded skin and toxic shock syndromes. Coagulase-negative staphylococci have become increasingly important causes of nosocomial bacteremia associated with invasive monitoring, intravascular catheters and prosthetic heart valves or joints. Most staphylococci produce b-lactamase and are resistant to penicillin. An increasing proportion of S. aureus have intrinsic resistance to methicillin (MRSA) and present major problems in hospitals for the control of cross infection. The glycopeptides, teicoplanin and vancomycin, are the antibiotics of first choice for treatment of these infections. After the first report describing a Japanese clinical isolate of vancomycin-resistant S. aureus (VRSA), several papers have documented the emergence of these microorganisms. Since the development and spreading of this phenomenon which is perceived as a fearsome threat to the already difficult therapy of nosocomial infections due to the prevalence of heterogeneous vancomycin resistance, we found the incidence of MRSA exceeds 35{\%} in our hospital. Out of 179 methicillin-resistant S. aureus isolated during 1997-1998, two strains (1.1{\%}) gave subclones with vancomycin MICs of 8 mg/L. PFGE showed identical restriction patterns for both isolates, suggesting transfer of a single clone between two different patients.",
keywords = "Glycopeptides, Gram-positive bacteria, Methicillin-resistance, Staphylococcus aureus, Teicoplanin, Vancomycin",
author = "A. Marchese and Schito, {G. C.} and Debbia, {E. A.}",
year = "2000",
language = "English",
volume = "12",
pages = "459--462",
journal = "Journal of Chemotherapy",
issn = "1120-009X",
publisher = "Maney Publishing",
number = "6",

}

TY - JOUR

T1 - Evolution of antibiotic resistance in gram-positive pathogens

AU - Marchese, A.

AU - Schito, G. C.

AU - Debbia, E. A.

PY - 2000

Y1 - 2000

N2 - Staphylococcus aureus is a common cause of soft-tissue infection, e.g. impetigo, cellulitis, or wound infection, and causes osteomyelitis, arthritis, bacteremia with metastatic infection, and scalded skin and toxic shock syndromes. Coagulase-negative staphylococci have become increasingly important causes of nosocomial bacteremia associated with invasive monitoring, intravascular catheters and prosthetic heart valves or joints. Most staphylococci produce b-lactamase and are resistant to penicillin. An increasing proportion of S. aureus have intrinsic resistance to methicillin (MRSA) and present major problems in hospitals for the control of cross infection. The glycopeptides, teicoplanin and vancomycin, are the antibiotics of first choice for treatment of these infections. After the first report describing a Japanese clinical isolate of vancomycin-resistant S. aureus (VRSA), several papers have documented the emergence of these microorganisms. Since the development and spreading of this phenomenon which is perceived as a fearsome threat to the already difficult therapy of nosocomial infections due to the prevalence of heterogeneous vancomycin resistance, we found the incidence of MRSA exceeds 35% in our hospital. Out of 179 methicillin-resistant S. aureus isolated during 1997-1998, two strains (1.1%) gave subclones with vancomycin MICs of 8 mg/L. PFGE showed identical restriction patterns for both isolates, suggesting transfer of a single clone between two different patients.

AB - Staphylococcus aureus is a common cause of soft-tissue infection, e.g. impetigo, cellulitis, or wound infection, and causes osteomyelitis, arthritis, bacteremia with metastatic infection, and scalded skin and toxic shock syndromes. Coagulase-negative staphylococci have become increasingly important causes of nosocomial bacteremia associated with invasive monitoring, intravascular catheters and prosthetic heart valves or joints. Most staphylococci produce b-lactamase and are resistant to penicillin. An increasing proportion of S. aureus have intrinsic resistance to methicillin (MRSA) and present major problems in hospitals for the control of cross infection. The glycopeptides, teicoplanin and vancomycin, are the antibiotics of first choice for treatment of these infections. After the first report describing a Japanese clinical isolate of vancomycin-resistant S. aureus (VRSA), several papers have documented the emergence of these microorganisms. Since the development and spreading of this phenomenon which is perceived as a fearsome threat to the already difficult therapy of nosocomial infections due to the prevalence of heterogeneous vancomycin resistance, we found the incidence of MRSA exceeds 35% in our hospital. Out of 179 methicillin-resistant S. aureus isolated during 1997-1998, two strains (1.1%) gave subclones with vancomycin MICs of 8 mg/L. PFGE showed identical restriction patterns for both isolates, suggesting transfer of a single clone between two different patients.

KW - Glycopeptides

KW - Gram-positive bacteria

KW - Methicillin-resistance

KW - Staphylococcus aureus

KW - Teicoplanin

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=0034520586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034520586&partnerID=8YFLogxK

M3 - Article

C2 - 11154025

AN - SCOPUS:0034520586

VL - 12

SP - 459

EP - 462

JO - Journal of Chemotherapy

JF - Journal of Chemotherapy

SN - 1120-009X

IS - 6

ER -